An in-silico approach for novel molecular glue design by rationalizing known molecular glue mediated ternary complex formation
Geoffrey A S, B.; Kulkarni, N. M.; Agrawal, D.; Bharti, N.; Vetrivel, R.; Gurram, K.
Show abstract
Protein function modulation using small molecule binding is an important therapeutic strategy for many diseases. However, many proteins remain undruggable due to lack of suitable binding pockets for small molecule binding. Proximity induced protein degradation using molecular glues has recently been identified as in important strategy to target the undruggable proteins. Molecular glues were discovered serendipitously and as such currently lack an established approach for in-silico design rationale. In this work, we attempt to establish the rationale for a known case and having inferred the rationale, we discuss how the rationale can be applied in-silico to design novel molecular glue through AI powered techniques. We believe the establishing of in-silico rationale for molecular glue design would be a valuable and welcome addition to the literature to further accelerate the discovery of molecular glues to drug undruggable targets.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for Acute Myeloid Leukaemia 97%
- Target2DeNovoDrugPropMax : a novel programmatic tool incorporating deep learning and in silico methods for automated de novo drug design for any target of interest 97%
- A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling 96%
Similar papers in this journal
- Identification of Family-Specific Features in Cas9 and Cas12 Proteins: A Machine Learning Approach Using Complete Protein Feature Spectrum 95%
- Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening 95%
- Structural characterization of LsrK to target quorum sensing and comparison between X-ray and homology model 94%
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 96%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 96%
Similar papers in this journal
- Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design 99%
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 96%
- Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer 94%
Similar papers in this journal
- Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal 95%
- Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay 92%
- Whole Genome Sequencing for Revealing the Point Mutations of SARS-CoV-2 Genome in Bangladeshi Isolates and their Structural Effects on Viral Proteins 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.